Industry-sponsored clinical research: a double-edged sword (Q34462055)

2 August 2017

1 reference

title

Industry-sponsored clinical research: a double-edged sword (English)

1 reference

2 August 2017

J S Montaner

1 reference

2 August 2017

M V O'Shaughnessy

series ordinal

1 reference

2 August 2017

M T Schechter

series ordinal

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

2 August 2017

1 reference

inferred from page(s)

published in

The Lancet

1 reference

2 August 2017

volume

358

1 reference

2 August 2017

issue

9296

1 reference

2 August 2017

page(s)

1893-1895

1 reference

The role of the research-based pharmaceutical industry in medical progress in the United States

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Decline in deaths from AIDS due to new antiretrovirals

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Uneasy alliance--clinical investigators and the pharmaceutical industry

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

The uncertainty principle and industry-sponsored research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Equipoise and the ethics of clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Source of funding and outcome of clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

The quality of drug studies published in symposium proceedings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Evaluation of conflict of interest in economic analyses of new drugs used in oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Withholding unfavourable results in drug company sponsored clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Publishing sensitive data: who calls the shots? Long-suppressed study finally sees light of day.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Influences on the quality of published drug studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

The exclusion of the elderly and women from clinical trials in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

The Cardiac Arrhythmia Pilot Study. The CAPS investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Organization, review, and administration of cooperative studies (greenberg report): A report from the heart special project committee to the National Advisory heart council, May 1967

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Assessing faculty financial relationships with industry: A case study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Is Academic Medicine for Sale?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Accepting commercial sponsorship. Disclosure helps--but is not a panacea

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

Policies on faculty conflicts of interest at US universities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2801%2906891-X

7 January 2021

10.1016/S0140-6736(01)06891-X

Identifiers

DOI

1 reference

2 August 2017

1 reference